Drug Trial Radar · NCT07102459
An Efficacy and Safety Study of LTG-001 Following Abdominoplasty
Last checked: Nov 19, 2026Latest source record: Apr 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
343
Actual
Start
Jul 24, 2025
Primary completion
Jan 7, 2026
Study completion Jan 7, 2026
Sponsor
- Lead sponsor
- Latigo BiotherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Aug 3, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if LTG-001 works to treat post-operative / acute pain after an abdominoplasty procedure. It will also learn more information on the safety of LTG-001. The main questions it aims to answer are: Does drug LTG-001 treat the acute pain after surgical abdominoplasty over 48 hours? How tolerable is LTG-001 over 48 hours? What dose of LTG-001 is better for treating post-operative / acute pain? Participants will: Take LTG-001 bid after the surgical abdominoplasty. Remain at the clinic for approximately 48 hours during study dosing and return after two weeks for a safety check up. Report the pain relief during the 48 hours to record changes in the post-operative pain.
Conditions
- Acute Pain
- Postoperative Pain Control
Interventions
Experimental: LTG-001 High DoseDrug
High Dose Active
Experimental: LTG-001 Low DoseDrug
Lower Dose Active
Active Comparator: HB/APAPDrug
Active Comparator
Placebo ComparatorDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- SPIDr0-48Time frame: 48 hours
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Arizona Research Center
Phoenix, Arizona
CenExel ACMR
Atlanta, Georgia
HD Research LLC
Houston, Texas
Endeavor Clinical Research
San Antonio, Texas
JBR Clinical Research (CenExel)
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.